Plant ID: NPO3909
Plant Latin Name: Leucas aspera
Taxonomy Genus: Leucas
Taxonomy Family: Lamiaceae
NCBI TaxonomyDB:
483811
Plant-of-the-World-Online:
n.a.
India; Philippines; China; Thailand
PTPN1; | |
AKR1B10; | |
MMP3; | |
CASP1; | |
MAPT; IL1B; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cysteine protease | CASP1 | Caspase-1 | P29466 | CHEMBL4801 |
Enzyme_unclassified | AKR1B10 | Aldo-keto reductase family 1 member B10 | O60218 | CHEMBL5983 |
Metallo protease | MMP3 | Matrix metalloproteinase 3 | P08254 | CHEMBL283 |
Protein Phosphatase | PTPN1 | Protein-tyrosine phosphatase 1B | P18031 | CHEMBL335 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
Unclassified | IL1B | Interleukin-1 beta | P01584 | CHEMBL1909490 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:2000377; regulation of reactive oxygen species metabolic process | 1.291E-05 | 7.529E-02 | IL1B, MAPT, MMP3 |
BP | GO:0009987; cellular process | GO:0080135; regulation of cellular response to stress | 1.806E-05 | 7.529E-02 | IL1B, MAPT, MMP3, PTPN1 |
BP | GO:0009987; cellular process | GO:0010941; regulation of cell death | 2.469E-05 | 7.529E-02 | CASP1, IL1B, MAPT, MMP3, PTPN1 |
BP | GO:0009987; cellular process | GO:0030947; regulation of vascular endothelial growth factor receptor signaling pathway | 2.605E-05 | 7.529E-02 | IL1B, PTPN1 |
BP | GO:0050896; response to stimulus | GO:0046627; negative regulation of insulin receptor signaling pathway | 3.484E-05 | 7.529E-02 | IL1B, PTPN1 |
MF | GO:0005488; binding | GO:0051721; protein phosphatase 2A binding | 3.029E-05 | 7.529E-02 | MAPT, PTPN1 |
MF | GO:0005488; binding | GO:0019904; protein domain specific binding | 8.551E-04 | 2.731E-01 | CASP1, IL1B, MAPT |
CC | GO:0044464; cell part | GO:0097443; sorting endosome | 1.863E-03 | 3.221E-01 | PTPN1 |
MF | GO:0003824; catalytic activity | GO:0001758; retinal dehydrogenase activity | 2.173E-03 | 3.221E-01 | AKR1B10 |
CC | GO:0044464; cell part | GO:0005764; lysosome | 2.896E-03 | 3.427E-01 | AKR1B10, IL1B |
MF | GO:0005488; binding | GO:0034452; dynactin binding | 3.412E-03 | 3.660E-01 | MAPT |
MF | GO:0003824; catalytic activity | GO:0097200; cysteine-type endopeptidase activity involved in execution phase of apoptosis | 4.032E-03 | 3.973E-01 | CASP1 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09160 Human Diseases | 09167 Infectious diseases | hsa05134 | Legionellosis | 1.106E-04 | 1.979E-03 | IL1B, CASP1 |
09150 Organismal Systems | 09151 Immune system | hsa04621 | NOD-like receptor signaling pathway | 1.188E-04 | 1.979E-03 | IL1B, CASP1 |
09150 Organismal Systems | 09151 Immune system | hsa04623 | Cytosolic DNA-sensing pathway | 1.500E-04 | 1.979E-03 | IL1B, CASP1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05133 | Pertussis | 2.061E-04 | 1.979E-03 | IL1B, CASP1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04668 | TNF signaling pathway | 4.432E-04 | 2.533E-03 | IL1B, MMP3 |
09160 Human Diseases | 09162 Immune diseases | hsa05323 | Rheumatoid arthritis | 2.969E-04 | 1.979E-03 | IL1B, MMP3 |
09160 Human Diseases | 09167 Infectious diseases | hsa05132 | Salmonella infection | 2.711E-04 | 1.979E-03 | IL1B, CASP1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05164 | Influenza A | 1.116E-03 | 4.959E-03 | IL1B, CASP1 |
09160 Human Diseases | 09163 Neurodegenerative diseases | hsa05010 | Alzheimer's disease | 1.029E-03 | 4.959E-03 | IL1B, MAPT |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04010 | MAPK signaling pathway | 2.348E-03 | 9.393E-03 | IL1B, MAPT |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Cognitive disorders | F01-F07, F04, F05, R41.3 | MAPT; |
G00-G99: Diseases of the nervous system G00-G99 | Neurodegenerative disease | G30-G32 | MAPT; |
G00-G99: Diseases of the nervous system G00-G99 | Central nervous system disease | G00-G99 | MAPT; |
G00-G99: Diseases of the nervous system G00-G99 | Epilepsy | G40 | CASP1; |
L00-L99: Diseases of the skin and subcutaneous tissue | Fibrosis | L90.5 | CASP1; |
A00-B99: Certain infectious and parasitic diseases | HCV infection | B17.1, B18.2 | MMP3; |
I00-I99: Diseases of the circulatory system | Ischemic stroke | I61-I63 | MMP3; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Osteoarthritis | M15-M19, M47 | MMP3; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Rheumatoid arthritis | M05-M06 | CASP1; MMP3; |
I00-I99: Diseases of the circulatory system | Myocardial infarction | I21, I22 | MMP3; |
G00-G99: Diseases of the nervous system G00-G99 | Alzheimer disease | G30 | MAPT; |
H00-H59: Diseases of the eye and adnexa | Corneal ulcers | H16.0 | MMP3; |